Picture of PAION AG logo

PA8 — PAION AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Paion: initiation of Remimazolan U.S. clinical safety trial in patiens undergoing colonoscopy

Dec 1 (Reuters) - Paion AG  PA8G.DE : 
    * Announces initiation of U.S. clinical safety trial of 
Remimazolam in high risk patients undergoing colonoscopy 
    * Completion of patient recruitment is expected in 2016 
 
Source text for Eikon:  ID:nEQ1QnYJha  
Further company coverage:  PA8G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))

Recent news on PAION AG

See all news